AKBA vs ICE · rev $160.2M vs P/E 37, rev $7.28B
Akebia Ther (AKBA) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported AKBA revenue for 2024-12-31 was $160.2M. Net income was -$69.4M. Revenue was down 17.7% from 2023-12-31 to 2024-12-31. AKBA currently screens at market cap $260.1M.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
AKBA currently screens at market cap $260.1M. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the AKBA and ICE stock pages for the full models.
Not investment advice.